🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-525333-22-00
Completed Phase I

SAR447971 first-in-human study

2026-525333-22-00 · tracked via the Priya Life Science EU tracker
Sponsor
Sanofi-Aventis Recherche & Developpement
Sponsor type
Pharmaceutical company
Therapeutic area
Immune System Diseases
Decision date
20/05/2026
Enrollment target
134
Sites
Netherlands

Condition studied

Hidradenitis

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-525333-22-00 on CTIS ↗ ← All trials in the EU